Inflammatory bowel disease (IBD) is an immune-mediated disease in
which the body’s own immune system attacks the parts of the digestive system of
the human body. Such disease involves inflammation of lower gastrointestinal
tract and causes irreversible damage to the bowel. Ulcerative colitis and
Crohn’s disease are the two major forms of IBD; both having distinct pathologic
and clinical characteristics. IBD is a difficult to manage medical condition
with a higher morbidity rate and thus its diagnosis and management is of utmost
importance.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/inflammatory-bowel-disease.html
The global inflammatory
bowel disease market is categorized as follows:
- Application
- Therapeutic
- Diagnostic
- Diseased condition
- Crohns disease
- Ulcerative colitis
- Product type
- Aminosalicylates
- Antibiotics
- Corticosteroids
- Biologic therapies (biological
drugs)
- Immunomodulators
Currently, the
developed global markets of North America and Europe make up for the majority
of the inflammatory bowel disease market in the world. Emerging markets of Asia
mainly India, Russia and Japan as well as countries of Middle East and Latin
America are also expected to show strong growth due to rising incidences of
such diseases owing to increased industrialization, modernization of the
population and drastic lifestyle changes.
One of the key factors
driving the growth of this market is the increase in use of biological
therapies such as monoclonal antibodies. However, difficulties involved in
affording the expensive treatments of such diseases may pose challenge to
growth of inflammatory bowel diseases market majorly in developing nations.
Some of the key players
in this industry are Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb
Company, Alcon, Inc., Baxter International, Inc., Johnson & Johnson,
Sequella, Inc., Sanofi-Aventis LLC, Osiris Therapeutics, Inc., AstraZeneca PLC,
Eisai Co. Ltd., Cephalon, Inc., Celltrion, Inc., Pfizer, Inc., Pluristem
Therapeutics, Inc., Soligenix, Inc. and Ore Pharmaceuticals, Inc.
Download PDF : Inflammatory Bowel Disease Market
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides
comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons for Buying this
Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological growth
map over time to understand the industry growth rate
- It provides a seven-year forecast
assessed on the basis of how the market is predicted to grow
·
It helps in making informed business
decisions by having complete insights of market and by making in-depth analysis
of market segments
More Reports On Pharmaceutical
Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us:-
Transparency Market
Research (TMR) is a market intelligence company providing global business
research reports and consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights for thousands
of decision-makers.
TMR’s
experienced team of analysts, researchers, and consultants use proprietary data
sources along with various tools and techniques to gather and analyze
information. Our business offerings represent the latest and the most reliable
information which is indispensable for businesses to sustain their competitive edge.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Researche Report:-
No comments:
Post a Comment